Amrutanjan Health Care (NSE:AMRUTANJAN) EPS (Basic): ₹20.03 (TTM As of Mar. 2026)


NSE:AMRUTANJAN Amrutanjan Health Care Ltd NSE:AMRUTANJAN
78 GF Score
Price ₹535.60
GF Value ₹818.74
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Amrutanjan Health Care EPS (Basic)?

Amrutanjan Health Care NSE:AMRUTANJAN -3.32% 78 EPS (Basic) is ₹20.03 as of Mar. 2026. GuruFocus rates NSE:AMRUTANJAN with a GF Score™ of 78/100 and a GF Value™ of ₹818.74 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Amrutanjan Health Care's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹5.60. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.03.

Amrutanjan Health Care's EPS (Diluted) for the three months ended in Mar. 2026 was ₹5.60. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.03.

Amrutanjan Health Care's EPS without NRI for the three months ended in Mar. 2026 was ₹5.60. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 20.35.

During the past 12 months, Amrutanjan Health Care's average EPS without NRIGrowth Rate was 15.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -3.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Amrutanjan Health Care's highest 3-Year average EPS without NRI Growth Rate was 52.80% per year. The lowest was -32.50% per year. And the median was 8.10% per year.

Amrutanjan Health Care  (NSE:AMRUTANJAN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Amrutanjan Health Care EPS (Basic) Related Terms

Amrutanjan Health Care EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Amrutanjan Health Care's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amrutanjan Health Care EPS (Basic) Chart

Amrutanjan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.00 13.65 15.50 17.58 20.03

Amrutanjan Health Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.25 2.87 4.83 6.73 5.60
NSE:AMRUTANJAN
78GF Score
Amrutanjan Health Care Ltd NSE:AMRUTANJAN
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amrutanjan Health Care EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Amrutanjan Health Care's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(579.178-0)/28.916
=20.03

Amrutanjan Health Care's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(161.928-0)/28.916
=5.60

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹20.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹20.03 mean?
Amrutanjan Health Care (NSE:AMRUTANJAN) has a EPS (Basic) of ₹20.03 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Amrutanjan Health Care and its competitors.
Is Amrutanjan Health Care's EPS (Basic) too high?
Amrutanjan Health Care's current EPS (Basic) is ₹20.03. Overall, Amrutanjan Health Care has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amrutanjan Health Care's EPS (Basic) compare to ZTS?
Amrutanjan Health Care's EPS (Basic) of ₹20.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Amrutanjan Health Care and its competitors. Amrutanjan Health Care's current EPS (Basic) is ₹20.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amrutanjan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Amrutanjan Health Care (NSE:AMRUTANJAN) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹818.74, compared to a current price of ₹535.60 — trading 34.6% below its estimated fair value. The current EPS (Basic) is ₹20.03. Amrutanjan Health Care's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Amrutanjan Health Care (NSE:AMRUTANJAN), the current EPS (Basic) is ₹20.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amrutanjan Health Care (NSE:AMRUTANJAN) Overvalued in 2026?

Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued. The current stock price of ₹535.60 is trading 34.6% below its estimated GF Value™ of ₹818.74. GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.

Key valuation signals for NSE:AMRUTANJAN:

  • EPS (Basic): ₹20.03
  • GF Value™: ₹818.74 vs. price of ₹535.60 (34.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the NSE:AMRUTANJAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amrutanjan Health Care Business Description

Other Exchanges 590006:India
Address No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
78GF Score

Get the complete analysis for NSE:AMRUTANJAN

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹535.60
Price
₹818.74
GF Value